Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
Feb 15, 2021
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:
Policy Notices
- Notice of Extension PA-17-008
Agency for Healthcare Research and Quality - Notice of Changes in the Review Criteria for Applications Submitted for NIH Support for Scientific Conferences (R13 and U13)
National Institutes of Health - Policy on Protecting Life in Global Health Assistance is Revoked
National Institutes of Health
General Notices
- Findings of Research Misconduct
National Institutes of Health - Notice of Pre-Application Webinar for RFA-TR-21-008, Multi-disciplinary Machine-assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey (UG3/UH3 Clinical Trial Optional)
National Center for Advancing Translational Sciences - Request for Information (RFI): Inviting Comments on the NCCIH Strategic Plan for Fiscal Years 2021-2025
National Center for Complementary and Integrative Health
Notice of Changes to Funding Opportunities
- Notice of Change to Eligibility of Foreign Components and Requirement for Letter of Support for PAR-21-109, "Early Stage Investigator Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed)
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs - Notice of Change to Key Dates for PA-21-110, "Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional)"
National Institute on Drug Abuse - Notice to Extend the Application Due Date for RFA-FD-21-014 - "Development of Methods to Evaluate the Impact of Design Differences to the User Interface of Generic Drug-Device Combination Products in Comparison to their Reference Listed Drugs (U01)"
Food and Drug Administration - Notice to correct email address for submission of Letter of Intent - RFA-FD-21-016 -Development of Advanced Analytical Methods for the Characterization of Iron Carbohydrate Complex - Ferric Derisomaltose (U01)
Food and Drug Administration - Notice to Extend the Application Due Date for RFA-FD-21-013 - Physiologically-based pharmacokinetic (PBPK) models to aid the development of generic dermatological products (U01) Clinical Trials Optional
Food and Drug Administration - Early Expiration of PAR-20-091 Revision Applications - FSMA Human Foods Preventive Controls Implementation Expansion Supplement to RFA-FD-18-001 (U18 Clinical Trials Not Allowed)
Food and Drug Administration - Notice of Early Expiration of NOT-MD-20-011 Notice of Special Interest: Health Services Research on Minority Health and Health Disparities (R01- Clinical Trial Optional)
National Institute on Minority Health and Health Disparities
Notices of Intent to Publish
- Notice of Intent to Publish a Funding Opportunity Announcement for Specialized Alcohol Research Centers (P50 Clinical Trial Optional)
National Institute on Alcohol Abuse and Alcoholism - Notice of Intent to Publish a Funding Opportunity Announcement for Comprehensive Alcohol Research Centers (P60 Clinical Trial Optional)
National Institute on Alcohol Abuse and Alcoholism - Notice of Intent to Publish a Funding Opportunity Announcement for Centers for HIV Structural Biology (U54 Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases - Notice of Intent to Publish a Funding Opportunity Announcement for Autism Centers of Excellence: Networks (R01 Clinical Trial Optional)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Deafness and Other Communication Disorders
National Institute of Environmental Health Sciences
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke - Notice of Intent to Publish a Funding Opportunity Announcement for Autism Centers of Excellence: Centers (P50 Clinical Trial Optional)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Deafness and Other Communication Disorders
National Institute of Environmental Health Sciences
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke - Notice of Intent to Publish a Research Opportunity Announcement for RADx-UP Return to School Diagnostic Testing Approaches (OT2 Clinical Trial Required)
National Institutes of Health
Notices of Special Interest
- Notice of Special Interest (NOSI): Secondary Analysis of Existing Datasets for Advancing Immune-mediated and Infectious Disease Research
National Institute of Allergy and Infectious Diseases
National Institute of Mental Health - Notice of Special Interest (NOSI): Telehealth Strategies for Individuals with HIV and Substance Use Disorders
National Institute on Drug Abuse - Notice of Special Interest: Availability of Administrative Supplements to INBRE Awards to Fund Research Collaborations
National Institute of General Medical Sciences - Notice of Special Interest (NOSI): Availability of Administrative Supplements for BRAIN Initiative Awardees to Support Resource Dissemination
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Mental Health - Notice of Special Interest (NOSI): Availability of Administrative Supplements for Submission of Tissue Chip Data to the Microphysiology Systems Database (MPS-Db)
National Center for Advancing Translational Sciences
Funding Opportunities
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
National Institutes of Health
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of General Medical Sciences
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Neurological Disorders and Stroke
National Library of Medicine
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
- Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care (R21/R33 - Clinical Trial Optional)
Agency for Healthcare Research and Quality
- NEI Translational Research Program (TRP) on Therapy for Visual Disorders (R24 Clinical Trial Optional)
National Eye Institute
- NIDCR Predoctoral to Postdoctoral Transition Award for a Diverse Dental, Oral and Craniofacial Research Workforce (F99/K00 Independent Clinical Trial Not Allowed)
National Institute of Dental and Craniofacial Research
- Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Limited Competition: Basic Instrumentation Grant (BIG) Program (S10 Clinical Trial Not Allowed)
The University of Iowa is not eligible for the BIG Program.
The BIG Program is limited to institutions that have not received S10 instrumentation funding of $250,001 or greater in any of the Federal fiscal years 2018-2020.
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
National Institute of General Medical Sciences
- High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed)
There is no restriction on the number of applications an institution can submit to the High-End Instrumentation Grant HEI and the Shared Instrumentation Grant SIG Programs each year, provided the applications request different types of equipment.
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
National Institute of General Medical Sciences
- Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)
There is no restriction on the number of applications an institution can submit to the Shared Instrumentation Grant SIG and the High-End Instrumentation Grant HEI Programs each year, provided the applications request different types of equipment.
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
- Basic Research to Inform Vaccine and Therapeutic Development for Non-Polio Human Enteroviruses (NPEV) (R01 Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases
- Expert-Driven Small Projects to Strengthen Gabriella Miller Kids First Discovery (R03 Clinical Trial Not Allowed)
Office of Strategic Coordination (Common Fund)
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 335-2123, or email Carrie Damon at carolyn-damon@uiowa.edu or Dave Myers at dave-myers@uiowa.edu or Lynn Hudachek at lynn-hudachek @uiowa.edu.